To better characterize sustained signaling consequences of 3 weeks of drug treatment, Western blot analysis of tumor lysates was used to evaluate expression or activation of a panel of proteins relevant to EGFR and AURKA function in tumors collected from treated mice at the end of the experiment (Fig. 5; Supplementary Figs. S2 and S3). The gene discussed is AURKA; the disease is neoplasm.